These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8180377)

  • 1. Deletion of chromosome 20q in myelodysplasia can occur in a multipotent precursor of both myeloid cells and B cells.
    White NJ; Nacheva E; Asimakopoulos FA; Bloxham D; Paul B; Green AR
    Blood; 1994 May; 83(10):2809-16. PubMed ID: 8180377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of chromosome 20q deletions in bone marrow metaphases but not peripheral blood granulocytes in patients with myeloproliferative disorders or myelodysplastic syndromes.
    Asimakopoulos FA; Holloway TL; Nacheva EP; Scott MA; Fenaux P; Green AR
    Blood; 1996 Feb; 87(4):1561-70. PubMed ID: 8608248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The human CD40 gene lies within chromosome 20q deletions associated with myeloid malignancies.
    Asimakopoulos FA; White NJ; Nacheva EP; Green AR
    Br J Haematol; 1996 Jan; 92(1):127-30. PubMed ID: 8562382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of chromosome arm 20q abnormalities in myeloid malignancies using genome-wide single nucleotide polymorphism array analysis.
    Huh J; Tiu RV; Gondek LP; O'Keefe CL; Jasek M; Makishima H; Jankowska AM; Jiang Y; Verma A; Theil KS; McDevitt MA; Maciejewski JP
    Genes Chromosomes Cancer; 2010 Apr; 49(4):390-9. PubMed ID: 20095039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular analysis of chromosome 20q deletions associated with myeloproliferative disorders and myelodysplastic syndromes.
    Asimakopoulos FA; White NJ; Nacheva E; Green AR
    Blood; 1994 Nov; 84(9):3086-94. PubMed ID: 7949181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deletions of chromosome 20q and the pathogenesis of myeloproliferative disorders.
    Asimakopoulos FA; Green AR
    Br J Haematol; 1996 Nov; 95(2):219-26. PubMed ID: 8904873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromosome 20 deletions in myeloid malignancies: reduction of the common deleted region, generation of a PAC/BAC contig and identification of candidate genes. UK Cancer Cytogenetics Group (UKCCG).
    Bench AJ; Nacheva EP; Hood TL; Holden JL; French L; Swanton S; Champion KM; Li J; Whittaker P; Stavrides G; Hunt AR; Huntly BJ; Campbell LJ; Bentley DR; Deloukas P; Green AR
    Oncogene; 2000 Aug; 19(34):3902-13. PubMed ID: 10952764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interstitial deletion constitutes the major mechanism for loss of heterozygosity on chromosome 20q in polycythemia vera.
    Asimakopoulos FA; Gilbert JG; Aldred MA; Pearson TC; Green AR
    Blood; 1996 Oct; 88(7):2690-8. PubMed ID: 8839864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myelodysplastic syndrome of del 20q with plasma cell dysplasia.
    Saito N; Higashiura K; Ehata K; Kurosawa S; Honma K; Abe M; Kimura A; Suzuki M; Nakamura S; Shiku H; Kean Ooi H
    J Clin Exp Hematop; 2011; 51(2):141-5. PubMed ID: 22104314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clonal involvement of granulocytes and monocytes, but not of T and B lymphocytes and natural killer cells in patients with myelodysplasia: analysis by X-linked restriction fragment length polymorphisms and polymerase chain reaction of the phosphoglycerate kinase gene.
    van Kamp H; Fibbe WE; Jansen RP; van der Keur M; de Graaff E; Willemze R; Landegent JE
    Blood; 1992 Oct; 80(7):1774-80. PubMed ID: 1356510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Distribution of abnormal cell clone with deletion of chromosome 20q in marrow cell lineages and apoptosis cells in myelodysplastic syndrome].
    Qin L; Wang C; Qin YW; Xie KC; Yan SK; Gao YR; Wang XR; Zhao CX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Jun; 16(3):551-4. PubMed ID: 18549627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of 20q deletions in patients with myeloproliferative disorders or myelodysplastic syndromes.
    Nacheva E; Holloway T; Carter N; Grace C; White N; Green AR
    Cancer Genet Cytogenet; 1995 Apr; 80(2):87-94. PubMed ID: 7736443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapy-related myeloid neoplasms with isolated del(20q): comparison with cases of de novo myelodysplastic syndrome with del(20q).
    Kanagal-Shamanna R; Yin CC; Miranda RN; Bueso-Ramos CE; Wang XI; Muddasani R; Medeiros LJ; Lu G
    Cancer Genet; 2013; 206(1-2):42-6. PubMed ID: 23357231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients With a History of Chemotherapy and Isolated del(20q) With Minimal Myelodysplasia Have an Indolent Course.
    Courville EL; Singh C; Yohe S; Linden MA; Naemi K; Berger M; Ustun C; McKenna RW; Dolan M
    Am J Clin Pathol; 2016 Apr; 145(4):459-66. PubMed ID: 27124938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isochromosome of a deleted 20q: a rare but recurrent chromosome abnormality in myelodysplastic syndromes.
    Saunders K; Czepulkowski B; Sivalingam R; Hayes JP; Aldouri M; Sekhar M; Cummins M; Ho A; Mufti GJ
    Cancer Genet Cytogenet; 2005 Jan; 156(2):154-7. PubMed ID: 15642396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromosome 20 deletions in myelodysplastic syndromes and Philadelphia-chromosome-negative myeloproliferative disorders: characterization by molecular cytogenetics of commonly deleted and retained regions.
    Douet-Guilbert N; Basinko A; Morel F; Le Bris MJ; Ugo V; Morice P; Berthou C; De Braekeleer M
    Ann Hematol; 2008 Jul; 87(7):537-44. PubMed ID: 18350294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unbalanced translocations of 20q in AML and MDS often involve interstitial rather than terminal deletions of 20q.
    MacKinnon RN; Duivenvoorden HM; Campbell LJ
    Cancer Genet; 2011 Mar; 204(3):153-61. PubMed ID: 21504715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myeloid but not lymphoid cells carry the 5q deletion: polymerase chain reaction analysis of loss of heterozygosity using mini-repeat sequences on highly purified cell fractions.
    Kroef MJ; Fibbe WE; Mout R; Jansen RP; Haak HL; Wessels JW; Van Kamp H; Willemze R; Landegent JE
    Blood; 1993 Apr; 81(7):1849-54. PubMed ID: 8461471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrospective evaluation of bone marrow cell morphology in a cohort of patients with isolated idic(20q-) karyotypic abnormalities.
    Liu D; Pan J; Wu C; Liang J; Wang J; Chen S; Chen Z
    Ann Hematol; 2019 Mar; 98(3):605-614. PubMed ID: 30483862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hematologic disorders associated with deletions of chromosome 20q: a clinicopathologic study of 107 patients.
    Kurtin PJ; Dewald GW; Shields DJ; Hanson CA
    Am J Clin Pathol; 1996 Nov; 106(5):680-8. PubMed ID: 8929482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.